Zentalis appoints James B. Bucher as Chief Legal Officer; Andrea Paul resigns to join law firm

Zentalis Pharmaceuticals, Inc.

Andrea Paul resigns as Chief Legal Officer and Corporate Secretary effective Sept 18, 2025.
James B. Bucher appointed as new Chief Legal Officer and Corporate Secretary effective same date.
Paul will remain a non-executive employee through Oct 1, 2025, and expects release agreement including 2025 bonus and equity vesting.
Bucher previously led legal at Harpoon Therapeutics during its Merck acquisition and at Alder Biopharmaceuticals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.